Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Interventional × Seizures × Clear all

Phase

Status

Completed 14 Recruiting 4 Unknown 3 Withdrawn 2 Active not recruiting 2 Terminated 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 343 Neoplasms 251 Carcinoma, Non-Small-Cell Lung 225 Colorectal Neoplasms 181 Lung Neoplasms 144 Prostatic Neoplasms 143 Carcinoma, Hepatocellular 120 Stomach Neoplasms 114 Multiple Myeloma 99 Pancreatic Neoplasms 88 Leukemia, Myeloid, Acute 87 Rectal Neoplasms 77 Squamous Cell Carcinoma of Head and Neck 76 Recurrence 75 Uterine Cervical Neoplasms 71 Neoplasm Metastasis 67 Ovarian Neoplasms 66 Small Cell Lung Carcinoma 64 Head and Neck Neoplasms 59 Glioblastoma 59 Brain Neoplasms 57 Triple Negative Breast Neoplasms 56 Esophageal Neoplasms 50 Endometrial Neoplasms 50 Colonic Neoplasms 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Motor Activity 43 Anxiety Disorders 43 Glioma 42 Hematologic Neoplasms 41

Interventions

Levetiracetam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05897658 2024-10-23

LeviTaTe Pilot

Hamilton Health Sciences Corporation

Phase 3 Not yet recruiting

Brain Neoplasms, Seizures

Data powered by HemOnc (CC BY 4.0) Colophon ⚡